Tata Consumer Q4 Results: Tata Consumer Products on Friday reported that its consolidated net profit of Rs 419 crore in the fourth quarter. This was higher by 21% from Rs 345 crore posted in the previous year quarter. Revenue from operations increased 18% YoY to Rs 5,434 crore.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,